Genomics Medicine: The missing link in bench-to-bedside translation
Thursday, March 23, 2017 from 9:00 AM to 1:00 PM (EDT)
San Francisco, California
London, United Kingdom
Thursday, March 23, 2017
SBP at Lake Nona, Medical City
9:00 am - 1:00 pm
Registration is from 8:30 am - 9:00 am
Questions? Contact us at GenomicsMedicine2017@SBPdiscovery.org
This symposium will focus on cancer genomics medicine and the role of genomics in cutting-edge clinical and laboratory research and cancer care management. Leading genomics scientists will discuss bench-to-bedside application of the latest discoveries in the field.
• Next generation DNA sequencing and related technologies
• Prognostic and diagnostic cancer genomics markers
• Genome restructuring and editing
• Genomic-guided drug therapies
• Personalized medicine
• Jane Gibson, Ph.D.
University of Central Florida
• Lawrence Lesko, Ph.D.
University of Florida College of Pharmacy
• Jonathan Licht, M.D.
University of Florida Health Cancer Center
• Jeffrey Boyd, Ph.D.
Miami Cancer Institute at Baptist Health South Florida
• F. Daniel Armstrong, Ph.D.
University of Miami Sylvester Comprehensive Cancer Center
• Garth Powis, D. Phil.
SBP Medical Discovery Institute,
NCI-designated Cancer Center
La Jolla, CA
• Gary Schroth, Ph.D.
Distinguished Scientist, and VP at Illumina Corporation
• Richard Finkel, M.D.
Nemours Children's Hospital
LEARN about the latest advances in genomic medicine.
DISCOVER best practices and challenges facing the implementation of genomic and personalized medicine.
STRATEGIZE how to integrate genomic testing and interpret results to patients and families.
Who Should Attend
Medical researchers, physicians, medical students, health care professionals and pharmaceutical and biotechnology company representatives.
This symposium is partially funded by the Bankhead-Coley Cancer Research Program which is administered through the Florida Department of Health.
Save This Event
When & Where
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute (SBP) is an independent nonprofit research organization that blends cutting-edge fundamental research with robust drug discovery to address unmet clinical needs in the areas of cancer, neuroscience, immunity, and metabolic disorders. The Institute invests in talent, technology, and partnerships to accelerate the translation of laboratory discoveries that will have the greatest impact on patients. Recognized for its world-class NCI-designated Cancer Center and the Conrad Prebys Center for Chemical Genomics, SBP employs more than 1,100 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at SBPdiscovery.org. The Institute can also be found on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.